{
    "Trade/Device Name(s)": [
        "Smart GBSTM Assay",
        "Cepheid Smart GBSTM Assay"
    ],
    "Submitter Information": "Cepheid",
    "510(k) Number": "K062948",
    "Predicate Device Reference 510(k) Number(s)": [
        "K022504"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NJR"
    ],
    "Summary Letter Date": "December 8, 2006",
    "Summary Letter Received Date": "September 28, 2006",
    "Submission Date": "September 27, 2006",
    "Regulation Number(s)": [
        "21 CFR 866.3740"
    ],
    "Regulation Name(s)": [
        "Streptococcus Spp. Serological Reagents"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Group B Streptococcus DNA",
        "Streptococcus agalactiae"
    ],
    "Specimen Type(s)": [
        "Vaginal swab",
        "Rectal swab",
        "Lim broth culture"
    ],
    "Specimen Container(s)": [
        "Copan with Liquid Stuart Medium"
    ],
    "Instrument(s)/Platform(s)": [
        "Cepheid SmartCycler Dx System"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Fluorogenic target-specific hybridization"
    ],
    "Methodologies": [
        "Nucleic acid amplification",
        "Molecular detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for Cepheid Smart GBS Assay using real-time PCR for detection of Group B Streptococcus DNA in vaginal/rectal swabs and Lim broth cultures.",
    "Indications for Use Summary": "Qualitative in vitro diagnostic test for rapid detection of Group B Streptococcus DNA from vaginal/rectal swab specimens and Lim broth cultures in antepartum and intrapartum women.",
    "fda_folder": "Microbiology"
}